PriceTargets.com logo

Align Technology - ALGN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $358.78
  • Forecasted Upside: 7.37%
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$334.14 As of 03/31/2023 01:00 AM ET
▲ +22.29 (7.15%)

This chart shows the closing price for ALGN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Align Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALGN

Analyst Price Target is $358.78
▲ +7.37% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Align Technology in the last 3 months. The average price target is $358.78, with a high forecast of $418.00 and a low forecast of $307.00. The average price target represents a 7.37% upside from the last price of $334.14.

This chart shows the closing price for ALGN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 contributing investment analysts is to buy stock in Align Technology. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/8/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
1/6/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/6/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/2/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2023

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/31/2023OTR GlobalUpgradeMixed ➝ PositiveLow
3/23/2023CICC ResearchInitiated CoverageMarket PerformLow
2/2/2023Evercore ISIBoost TargetOutperform$230.00 ➝ $375.00Low
2/2/2023Stifel NicolausBoost TargetBuy$265.00 ➝ $375.00Low
2/2/2023The Goldman Sachs GroupUpgradeSell ➝ Neutral$165.00 ➝ $307.00Low
2/2/2023Robert W. BairdBoost TargetOutperform$260.00 ➝ $335.00Low
2/2/2023Piper SandlerBoost TargetOverweight$255.00 ➝ $360.00N/A
1/11/2023Piper SandlerBoost TargetOverweight$230.00 ➝ $255.00Low
10/27/2022The Goldman Sachs GroupLower TargetSell$250.00 ➝ $165.00Low
10/27/2022Morgan StanleyLower TargetOverweight$402.00 ➝ $314.00Low
10/27/2022Stifel NicolausLower Target$325.00 ➝ $265.00Low
10/27/2022Robert W. BairdLower Target$310.00 ➝ $260.00Low
10/27/2022Piper SandlerLower Target$300.00 ➝ $230.00Low
10/13/2022Piper SandlerLower TargetOverweight$340.00 ➝ $300.00Low
10/12/2022Stifel NicolausLower TargetBuy ➝ Buy$375.00 ➝ $325.00Low
9/9/2022Piper SandlerLower TargetOverweight$370.00 ➝ $340.00Low
7/29/2022UBS GroupLower TargetBuy$380.00 ➝ $370.00Low
7/28/2022StephensLower TargetOverweight$500.00 ➝ $375.00Low
7/28/2022Morgan StanleyLower TargetOverweight$438.00 ➝ $402.00Low
7/28/2022Evercore ISILower Target$310.00 ➝ $285.00Low
7/28/2022Robert W. BairdLower TargetOutperform$450.00 ➝ $410.00Low
7/28/2022The Goldman Sachs GroupDowngradeBuy ➝ Sell$380.00 ➝ $250.00Low
7/22/2022Piper SandlerLower TargetOverweight$440.00 ➝ $370.00Low
7/20/2022Morgan StanleyLower TargetOverweight$479.00 ➝ $438.00Low
7/18/2022UBS GroupLower Target$410.00 ➝ $380.00Low
7/14/2022Stifel NicolausLower TargetBuy$425.00 ➝ $375.00Low
6/15/2022Morgan StanleyLower TargetOverweight$524.00 ➝ $479.00Low
5/4/2022Credit Suisse GroupLower Target$722.00 ➝ $418.00Medium
4/28/2022Stifel NicolausLower Target$575.00 ➝ $425.00High
4/28/2022Morgan StanleyLower Target$575.00 ➝ $524.00High
4/28/2022Robert W. BairdLower TargetOutperform$625.00 ➝ $510.00High
4/28/2022Piper SandlerLower Target$600.00 ➝ $440.00High
4/26/2022UBS GroupLower TargetBuy$620.00 ➝ $500.00Medium
4/21/2022Piper SandlerLower TargetOverweight$740.00 ➝ $600.00High
2/3/2022Robert W. BairdLower Target$745.00 ➝ $650.00High
2/3/2022Stifel NicolausLower TargetBuy$675.00 ➝ $625.00High
2/3/2022Credit Suisse GroupLower TargetOutperform$782.00 ➝ $722.00High
1/31/2022UBS GroupUpgradeNeutral ➝ Buy$880.00 ➝ $620.00High
1/31/2022Morgan StanleyInitiated CoverageOverweight$575.00High
1/21/2022Stifel NicolausLower Target$750.00 ➝ $675.00High
11/1/2021William BlairReiterated RatingOutperformLow
10/28/2021The Goldman Sachs GroupDowngradeBuy$810.00High
10/28/2021Piper SandlerBoost TargetPositive ➝ Overweight$775.00 ➝ $825.00High
7/29/2021William BlairReiterated RatingOutperformHigh
7/29/2021Credit Suisse GroupBoost TargetOutperform ➝ Outperform$715.00 ➝ $732.00High
7/29/2021Piper SandlerBoost TargetOverweight$735.00 ➝ $775.00High
7/9/2021StephensUpgradeEqual Weight ➝ Overweight$600.00 ➝ $700.00Medium
7/8/2021Exane BNP ParibasInitiated CoverageOutperform$790.00Medium
7/8/2021BNP ParibasInitiated CoverageOutperform$790.00Medium
4/29/2021SVB LeerinkBoost TargetPositive ➝ Outperform$690.00 ➝ $770.00High
4/29/2021Credit Suisse GroupBoost TargetOutperform$693.00 ➝ $715.00High
4/29/2021Stifel NicolausBoost TargetBuy$650.00 ➝ $750.00High
4/29/2021Robert W. BairdBoost TargetOutperform$655.00 ➝ $745.00High
4/29/2021Piper SandlerBoost TargetOverweight$700.00 ➝ $735.00High
4/22/2021Berenberg BankUpgradeHold ➝ Buy$683.00Medium
4/15/2021SVB LeerinkBoost TargetOutperform$680.00 ➝ $690.00Medium
2/4/2021Evercore ISIBoost TargetOutperform$625.00 ➝ $680.00High
2/4/2021Credit Suisse GroupBoost TargetOutperform$618.00 ➝ $630.00High
2/4/2021SVB LeerinkBoost TargetOutperform$620.00 ➝ $680.00High
2/4/2021BarclaysBoost TargetEqual Weight$475.00 ➝ $555.00High
2/2/2021Piper SandlerBoost TargetOverweight$525.00 ➝ $610.00Low
1/4/2021Evercore ISIUpgradeIn-Line ➝ Outperform$625.00N/A
11/24/2020Credit Suisse GroupBoost TargetOutperform$432.00 ➝ $515.00Medium
11/24/2020SVB LeerinkBoost TargetOutperform$460.00 ➝ $520.00Medium
11/24/2020The Goldman Sachs GroupBoost TargetBuy$472.00 ➝ $535.00Medium
11/24/2020Robert W. BairdBoost TargetOutperform$450.00 ➝ $530.00Medium
11/23/2020Piper SandlerBoost TargetOverweight$500.00 ➝ $525.00Medium
10/28/2020Stifel NicolausBoost TargetBuy$460.00 ➝ $515.00Low
10/22/2020Robert W. BairdBoost Target$370.00 ➝ $450.00High
10/22/2020Stifel NicolausBoost TargetBuy$360.00 ➝ $460.00High
10/22/2020BarclaysBoost TargetEqual Weight$300.00 ➝ $400.00High
10/22/2020Piper SandlerBoost TargetOverweight$400.00 ➝ $500.00High
10/22/2020Jefferies Financial GroupBoost TargetBuy$355.00 ➝ $450.00High
10/22/2020Credit Suisse GroupBoost TargetOutperform$348.00 ➝ $432.00High
10/22/2020SVB LeerinkBoost TargetOutperform$340.00 ➝ $460.00High
7/29/2020Berenberg BankDowngradeBuy ➝ Hold$306.00Low
7/23/2020BarclaysDowngradeOverweight ➝ Equal Weight$225.00 ➝ $300.00High
7/23/2020SVB LeerinkBoost TargetOutperform$310.00 ➝ $340.00High
7/23/2020Piper SandlerBoost TargetOverweight$258.00 ➝ $345.00High
7/20/2020Bank of AmericaDowngradeNeutral ➝ Underperform$280.00Low
7/14/2020SVB LeerinkBoost TargetOutperform$260.00 ➝ $310.00High
6/12/2020OTR GlobalUpgradePositiveLow
6/12/2020Stifel NicolausBoost TargetBuy$275.00 ➝ $300.00Low
5/22/2020Stifel NicolausBoost TargetBuy$230.00 ➝ $275.00High
5/1/2020UBS GroupLower TargetNeutral$270.00 ➝ $245.00Low
4/30/2020SVB LeerinkReiterated RatingOutperformLow
4/30/2020Credit Suisse GroupLower TargetOutperform$320.00 ➝ $275.00Low
4/30/2020Robert W. BairdBoost TargetOutperform$225.00 ➝ $248.00Low
4/30/2020Piper SandlerLower TargetOverweight$275.00 ➝ $258.00Low
3/19/2020StephensLower TargetEqual Weight$220.00 ➝ $165.00High
3/13/2020Stifel NicolausLower TargetBuy$305.00 ➝ $275.00High
3/5/2020Robert W. BairdReiterated RatingBuy$325.00Medium
1/30/2020Piper SandlerBoost Target$240.00 ➝ $275.00Medium
1/28/2020UBS GroupBoost TargetNeutral$235.00 ➝ $280.00Medium
1/9/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$360.00Medium
11/19/2019StephensReiterated RatingHold$220.00Medium
11/18/2019Stifel NicolausBoost TargetBuy$290.00 ➝ $305.00Medium
10/24/2019Bank of AmericaBoost TargetNeutral$220.00 ➝ $240.00High
10/7/2019BarclaysLower TargetOverweight$300.00 ➝ $272.00High
10/7/2019GuggenheimDowngradeBuy ➝ Neutral$250.00 ➝ $200.00High
7/31/2019Piper Jaffray CompaniesSet TargetBuy$240.00N/A
7/26/2019UBS GroupSet TargetHold$230.00Medium
7/26/2019Robert W. BairdLower TargetOutperform$336.00 ➝ $259.00Medium
7/25/2019Stifel NicolausLower TargetBuy$360.00 ➝ $290.00Low
7/25/2019Bank of AmericaDowngradeBuy ➝ NeutralMedium
7/25/2019Credit Suisse GroupLower TargetOutperform$340.00 ➝ $320.00High
7/25/2019Piper Jaffray CompaniesLower TargetOverweight$350.00 ➝ $240.00High
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformMedium
4/26/2019UBS GroupSet TargetHold$325.00Low
4/25/2019Credit Suisse GroupBoost TargetOutperform$305.00 ➝ $316.00High
4/25/2019BarclaysBoost TargetOverweight ➝ Overweight$335.00 ➝ $355.00Low
4/25/2019Piper Jaffray CompaniesBoost TargetOverweight$300.00 ➝ $350.00Medium
4/17/2019GuggenheimInitiated CoverageBuy ➝ Buy$335.00High
4/11/2019BarclaysSet TargetBuy$325.00Low
3/25/2019Credit Suisse GroupBoost TargetOutperform$270.00 ➝ $278.00Low
3/19/2019Piper Jaffray CompaniesBoost TargetOverweight$250.00 ➝ $300.00Medium
3/14/2019OTR GlobalDowngradePositiveLow
3/5/2019Robert W. BairdBoost TargetOutperform ➝ Outperform$255.00 ➝ $286.00High
2/14/2019UBS GroupDowngradeBuy ➝ Neutral$275.00Low
1/30/2019Credit Suisse GroupLower TargetOutperform$277.00 ➝ $270.00High
1/30/2019SVB LeerinkLower TargetOutperform$300.00 ➝ $285.00High
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$230.00High
1/6/2019BarclaysReiterated RatingBuy$275.00Medium
1/4/2019Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$300.00 ➝ $210.00Low
1/2/2019Robert W. BairdLower TargetOutperform$330.00 ➝ $255.00High
11/20/2018Credit Suisse GroupLower TargetOutperform ➝ Outperform$375.00 ➝ $343.00High
11/19/2018William BlairReiterated RatingOutperformHigh
10/25/2018Morgan StanleyLower TargetEqual Weight$320.00 ➝ $300.00High
10/25/2018Credit Suisse GroupLower TargetOutperform$391.00 ➝ $375.00High
10/25/2018Robert W. BairdLower TargetOutperform$425.00 ➝ $330.00High
10/25/2018Stifel NicolausLower TargetAverage ➝ Buy$425.00 ➝ $346.00High
10/20/2018The Goldman Sachs GroupInitiated CoverageBuy$420.00Low
10/9/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$315.00 ➝ $320.00Low
7/26/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$340.00 ➝ $391.00Medium
7/26/2018SVB LeerinkBoost TargetOutperform$400.00 ➝ $420.00Medium
7/26/2018BarclaysReiterated RatingBuyHigh
7/26/2018Robert W. BairdBoost TargetOutperform$351.00 ➝ $425.00High
7/26/2018Stifel NicolausBoost TargetBuy ➝ Buy$375.00 ➝ $425.00High
7/20/2018Piper Jaffray CompaniesBoost TargetOverweight$425.00Low
7/13/2018Morgan StanleyBoost TargetEqual Weight$290.00 ➝ $315.00Low
7/13/2018Stifel NicolausBoost TargetBuy$350.00 ➝ $375.00Low
6/26/2018Northcoast ResearchReiterated RatingBuy$430.00Low
6/25/2018Bank of AmericaInitiated CoverageBuy$420.00Low
6/21/2018BarclaysBoost TargetOverweight$410.00Medium
6/1/2018Stifel NicolausReiterated RatingBuy$320.00 ➝ $350.00Low
5/25/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$300.00 ➝ $340.00Low
5/24/2018Piper Jaffray CompaniesBoost TargetOverweight ➝ Overweight$300.00 ➝ $325.00High
5/24/2018Jefferies Financial GroupBoost TargetBuy$350.00High
5/24/2018SVB LeerinkBoost TargetOutperform ➝ Outperform$305.00 ➝ $360.00High
5/22/2018Stifel NicolausBoost TargetBuy ➝ Buy$320.00 ➝ $350.00Medium
5/21/2018BarclaysBoost TargetOverweight ➝ Overweight$295.00 ➝ $325.00Medium
5/16/2018Evercore ISIInitiated CoverageOutperform$340.00Low
4/26/2018Credit Suisse GroupBoost TargetOutperform ➝ Outperform$290.00 ➝ $300.00High
4/26/2018BarclaysBoost TargetOverweight ➝ Overweight$290.00 ➝ $295.00High
4/26/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$270.00 ➝ $290.00Low
4/26/2018Stifel NicolausBoost TargetBuy ➝ Buy$295.00 ➝ $320.00Medium
4/20/2018Berenberg BankInitiated CoverageBuy$305.00High
4/19/2018Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$220.00High
4/18/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$300.00 ➝ $270.00High
(Data available from 4/1/2018 forward)

News Sentiment Rating

0.98 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/3/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
10/3/2022
  • 5 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
11/2/2022
  • 3 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/2/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/1/2023
  • 9 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/31/2023
  • 18 very positive mentions
  • 32 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 17 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023

Current Sentiment

  • 17 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Align Technology logo
Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Read More

Today's Range

Now: $334.14
Low: $315.00
High: $335.15

50 Day Range

MA: $311.79
Low: $251.38
High: $359.88

52 Week Range

Now: $334.14
Low: $172.05
High: $458.25

Volume

1,215,289 shs

Average Volume

978,279 shs

Market Capitalization

$25.60 billion

P/E Ratio

72.48

Dividend Yield

N/A

Beta

1.6

Frequently Asked Questions

What sell-side analysts currently cover shares of Align Technology?

The following equities research analysts have issued stock ratings on Align Technology in the last twelve months: CICC Research, Credit Suisse Group AG, Evercore ISI, Morgan Stanley, OTR Global, Piper Sandler, Robert W. Baird, Stephens, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, and UBS Group AG.
View the latest analyst ratings for ALGN.

What is the current price target for Align Technology?

9 Wall Street analysts have set twelve-month price targets for Align Technology in the last year. Their average twelve-month price target is $358.78, suggesting a possible upside of 7.4%. Credit Suisse Group AG has the highest price target set, predicting ALGN will reach $418.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $307.00 for Align Technology in the next year.
View the latest price targets for ALGN.

What is the current consensus analyst rating for Align Technology?

Align Technology currently has 2 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ALGN will outperform the market and that investors should add to their positions of Align Technology.
View the latest ratings for ALGN.

What other companies compete with Align Technology?

Other companies that are similar to Align Technology include Zimmer Biomet, STERIS, Smith & Nephew, Edwards Lifesciences and Intuitive Surgical. Learn More about companies similar to Align Technology.

How do I contact Align Technology's investor relations team?

Align Technology's physical mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider's listed phone number is (602) 742-2000 and its investor relations email address is [email protected] The official website for Align Technology is www.aligntech.com. Learn More about contacing Align Technology investor relations.